Zentek (TSE:ZEN) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Zentek’s subsidiary, Triera Biosciences, has secured a $1.1 million contract from the Government of Canada to test its innovative multivalent aptamer technology. This funding will support the development of rapid drug discovery solutions for highly pathogenic avian influenza, showcasing the government’s commitment to advancing the life sciences sector in Canada.
For further insights into TSE:ZEN stock, check out TipRanks’ Stock Analysis page.
